Creative Medical Technology Holdings, Inc.
CELZ
Rank in Stocks
#32467
Creative Medical Technology Holdings, Inc., a biotechnology firm based in... Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Share Price
$0.6121
Last synced: 2026-11-09
Market Cap
$1.58M
Change (1 day)
-1.59%
Change (1 year)
-80.87%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Creative Medical Technology Holdings, Inc. (CELZ)
Category
Healthcare
Operating Margin for Creative Medical Technology Holdings, Inc. (CELZ)
Operating Margin as of November 2026 TTM: -208,004.40%
According to Creative Medical Technology Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -208,004.40%. At the end of 2025 the company had an operating margin of -102,380.23%.
Operating Margin history for Creative Medical Technology Holdings, Inc. from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -208,004.40% | 103.17% |
| 2025 | -102,380.23% | 96.07% |
| 2024 | -52,216.92% | -16.38% |
| 2023 | -62,445.91% | 440.07% |
| 2022 | -11,562.50% | 224.59% |
| 2021 | -3,562.17% | 425.62% |
| 2020 | -677.71% | -0.76% |
| 2019 | -682.88% | -23.76% |
| 2018 | -895.68% | -96.35% |
| 2017 | -24,537.63% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -100.00% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Creative Medical Technology Holdings, Inc.'s operating margin
What is Creative Medical Technology Holdings, Inc.'s operating margin?
Creative Medical Technology Holdings, Inc.'s operating margin is -208,004.40%, as of Nov 2026.
What was Creative Medical Technology Holdings, Inc.'s operating margin in 2025?
In 2025, Creative Medical Technology Holdings, Inc.'s operating margin was -102,380.23%, compared with -52,216.92% in 2024.
How has Creative Medical Technology Holdings, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Creative Medical Technology Holdings, Inc.'s operating margin was highest in 2020 (-677.71%) and lowest in 2025 (-102,380.23%).
How does Creative Medical Technology Holdings, Inc.'s operating margin compare with similar companies?
Creative Medical Technology Holdings, Inc.'s operating margin (-208,004.40%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.